ACID AND ALKALI-RESISTANT AND THERMOSTABILIZED ANTIMICROBIAL PEPTIDES, AND MANUFACTURE METHODS AND APPLICATIONS THEREOF
An acid and alkali-resistant, as well as thermostabilized antimicrobial peptide is provided. This peptide is engineered to endure extreme pH conditions, high temperatures, and sustain its natural conformation. This is achieved by bonding the antimicrobial peptide with a structure-lock component via non-covalent interactions, effectively preserving its biologically active conformation. Moreover, the antimicrobial peptide is enveloped within a controlled release encapsulation material, facilitating controlled and sustained release in diverse applications.
1 . An acid and alkali-resistant and thermostabilized antimicrobial peptide, wherein the acid and alkali-resistant and thermostabilized antimicrobial peptide is an antimicrobial peptide bond with a structure-lock component through a non-covalent bond to maintain the antimicrobial peptide in its native conformation and encapsulated by a controlled release encapsulation material.
2 . The acid and alkali-resistant and thermostabilized antimicrobial peptide of claim 1 , wherein the non-covalent bond is selected from a hydrogen bond, a Van der Waals bond, a hydrophobic interaction or an electrostatic interaction.
3 . The acid and alkali-resistant and thermostabilized antimicrobial peptide of claim 1 , wherein the structure-lock component binds to hydrophobic residues of the antimicrobial peptide.
4 . The acid and alkali-resistant and thermostabilized antimicrobial peptide of claim 1 , wherein the antimicrobial peptide is selected from nisin, polylysine, cecropin, defensin, bacitracin, lacticin, a salt thereof or any combinations thereof.
5 . The acid and alkali-resistant and thermostabilized antimicrobial peptide of claim 1 , wherein the structure-lock component is selected from cyclodextrins, polylysine, zein, silk fibroin, silk sericin, a salt thereof or any combinations thereof.
6 . The acid and alkali-resistant and thermostabilized antimicrobial peptide of claim 1 , wherein the encapsulation material is a polymer or a lipid component, comprising a polyvinylpyrrolidone, a solid lipid, a natural wax and a salt thereof.
7 . The acid and alkali-resistant and thermostabilized antimicrobial peptide of claim 1 , wherein the acid and alkali-resistant and thermostabilized antimicrobial peptide has an antimicrobial effect against Escherichia coli, Staphylococcus aureus and Candida albicans for at least 99%.
8 . The acid and alkali-resistant and thermostabilized antimicrobial peptide of claim 1 , wherein the acid and alkali-resistant and thermostabilized antimicrobial peptide is stable and functioned at a pH value range of 4-10.
9 . The acid and alkali-resistant and thermostabilized antimicrobial peptide of claim 1 , wherein the acid and alkali-resistant and thermostabilized antimicrobial peptide is stable and functioned at a temperature range of 0-120° C.
10 . A method for manufacturing an acid and alkali-resistant and thermostabilized antimicrobial peptide, comprising:
capping and/or grafting a structure-lock component on the hydrophobic residues of an antimicrobial peptide to obtain a structural-locked peptide; and
homogenizing the structural-locked peptide with an encapsulation material and a membrane penetration enhancer in a solvent to form an acid and alkali-resistant and thermostabilized antimicrobial peptide.
11 . The method of claim 10 , wherein the weight percentages of the antimicrobial peptide, the structure-lock component, the encapsulation material, the membrane penetration enhancer and the solvent are 0.5-38 wt. %, 0.5-38 wt. %, 0.01-5 wt. %, 0.01-47 wt. % and 0-98.98%, respectively.
12 . The method of claim 11 , wherein the antimicrobial peptide is 0.5-1 wt. %, the structure-lock component is 0.5-1 wt. %, the encapsulation material is 0.01-0.1 wt. %, the membrane penetration enhancer is 0.01-0.5 5 wt. % and the solvent is 97.35-98.98 wt. %.
13 . The method of claim 11 , wherein the antimicrobial peptide is 25-38 wt. %, the structure-lock component is 25-38 wt. %, the encapsulation material is 3-5 wt. % and the membrane penetration enhancer is 19-47 wt. %.
14 . The method of claim 10 , wherein the size of the structural-locked peptide is in a range of 100-1000 nm.
15 . The method of claim 10 , wherein the antimicrobial peptide is selected from nisin, polylysine, cecropin, defensin, bacitracin, lacticin, a salt thereof or any combinations thereof.
16 . The method of claim 10 , wherein the structure-lock component is selected from cyclodextrins, polylysine, zein, silk fibroin, silk sericin, a salt thereof or any combinations thereof.
17 . The method of claim 10 , wherein the encapsulation material is a polymer or a lipid component, comprising a polyvinylpyrrolidone, a solid lipid, a natural wax and a salt thereof.
18 . The method of claim 10 , wherein the membrane penetration enhancer is selected from citric acid, phytic acid, myristic acid, fumaric acid, mandelic acid, succinic acid, lauric acid, honokiol, poly-L-lysine or a salt thereof.
19 . The method of claim 10 , wherein the solvent is selected from water, isopropyl alcohol or ethyl alcohol.
20 . An acid and alkali-resistant, thermostabilized and non-toxic preservative, comprising the acid and alkali-resistant and thermostabilized antimicrobial peptide of claim 1 .
21 . An acid and alkali-resistant, thermostabilized and non-toxic food addictive, comprising the acid and alkali-resistant and thermostabilized antimicrobial peptide of claim 1 .